Heart attack | Page 24 of 45

Heart Failure :: Cardiovascular protective benefits of carvedilol in heart failure patients

Patients with heart failure who received the heart medication carvedilol suffered fewer heart attacks and strokes and were less likely to die of these and other vascular events than patients prescribed another beta blocker, metoprolol tartrate, according to a retrospective analysis of COMET (the Carvedilol or Metoprolol European Trial) published in the March 6th issue of The Journal of the American College of Cardiology.

Stem Cell :: Type of stem cell found to reside in transplanted lungs

A new study involving a type of stem cells from the lungs of transplant patients demonstrates for the first time that these progenitor cells reside in adult organs and are not derived from bone marrow, which leads to the possibility that the cells may be able to help with the rejection of donated organs and with various kinds of lung disease.

Heart Attack :: Latin Americans can reduce heart attack risk by lifestyle changes

The three major risk factors for heart attacks among Latin Americans could be reduced through lifestyle changes, according to a study published in Circulation: Journal of the American Heart Association in a special Latin American-themed issue called Heart Disease in Latin America.

Heart Failure :: Increases in fasting glucose raised the risk of congestive heart failure

Fasting glucose levels may independently predict the risk of being hospitalized with congestive heart failure in heart attack survivors and others who are at high risk of developing the disorder, researchers reported in Circulation: Journal of the American Heart Association.

Heart Disease :: Pfizer’s Lipitor for 5 new indications in patients with heart disease

Pfizer announced that the U.S. Food and Drug Administration (FDA) has approved Lipitor? (atorvastatin calcium) Tablets to reduce the risk of nonfatal heart attacks, fatal and non-fatal strokes, certain types of heart surgery, hospitalization for heart failure, and chest pain in patients with heart disease.

Heart :: $15M Northwestern grant funds heart research

An estimated 100,000 patients who have heart attacks each year are not eligible for life-saving beta-blocker drug therapy because their heart rates are too low. Beta-blockers improve survival rates up to 30 percent in people who have had heart attacks by helping to regulate the heartbeat.

Heart Disease :: Breast cancer survivors experience heart disease risk from radiotherapy

Women who were treated with radiation for breast cancer during the 1980s may be at an increased risk for heart disease compared with the general population, according to a new study in the March 7 Journal of the National Cancer Institute.

Heart Care :: Do specialty heart hospitals drive up heart care use?

Across the country, states are embroiled in a debate over “specialty hospitals” ? physician-owned hospitals that focus on a single disease process such as heart care or orthopedics. The debate has intensified ever since a federal government moratorium on opening new specialty hospitals expired last year.

Mental Health :: Blood tests may be possible for mental health conditions

Blood tests for panic disorder and other mental health conditions are potentially around the corner, based on results from a University of Iowa study. The findings, which were based on analysis of genetic information in lymphoblasts, or immature white blood cells, appear online March 6 in the American Journal of Medical Genetics.

Sleep Apnea :: Sleep apnea increases stroke, heart disease risk

In celebration of National Sleep Awareness Week, March 5 ? 11, Loyola University Health System?s Center for Sleep Disorders is encouraging people who snore loudly, hear themselves (or are told that they) gasp for air at night or wake up groggy to be evaluated for sleep apnea, a potentially deadly, but easily treatable, sleep disorder that raises the risk of heart attack and stroke.